Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ciclopirox | 2812 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | ciclopirox | 2812 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | ciclopirox | 2812 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | ciclopirox | 2812 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | ciclopirox | 2812 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | ciclopirox | 2812 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ciclopirox | 2812 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | ciclopirox | 2812 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | hexetidine | 3607 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | hexetidine | 3607 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | hexetidine | 3607 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | hexetidine | 3607 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | hexetidine | 3607 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | hexetidine | 3607 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | hexetidine | 3607 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | hexetidine | 3607 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | hexetidine | 3607 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | hexetidine | 3607 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | ritodrine | 688570 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | ritodrine | 688570 | drug-path |